Cost-effectiveness analysis of seasonal malaria chemoprophylaxis in children under 5 years of age in the Collines department of Benin in 2025
DOI:
https://doi.org/10.4314/rasp.v8i1.16Keywords:
Seasonal malaria chemoprevention, cost-effectiveness analysis, children under 5 years, Benin, Monte CarloAbstract
Malaria remains a major public health challenge in sub-Saharan Africa, accounting for 40% of consultations and the leading cause of mortality among children under 5 years in Benin. This study aimed to analyze the cost-effectiveness of Seasonal Malaria Chemoprevention (SMC) among children under 5 years in the Collines department of Benin in 2025. This was a cost-effectiveness analysis conducted from March to April 2025, including 454 households selected through multi-stage probability sampling. Data were analyzed using Stata 18.4 and Python 3.10. Univariate and multivariate sensitivity analyses were performed with Monte Carlo simulations over 10,000 iterations. SMC achieved a 19.94% reduction in malaria cases and 32.50% reduction in deaths between 2023 and 2024. The total cost was 246,505,194.5 FCFA. The cost per DALY averted was 123,376 FCFA, 6.5 times below the WHO "very cost-effective" threshold. The probability of cost-effectiveness was 100% across all 10,000 simulations. SMC is a highly cost-effective intervention. Transitioning to a DOT3 strategy is recommended to maximize health and economic impact.
Downloads
References
ACCESS-SMC Partnership. (2020). Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study. The Lancet, 396(10265), 1829-1840. https://doi.org/10.1016/S0140-6736(20)32227-3
Diawara, H., Walker, P., Cairns, M., Steinhardt, L. C., Diawara, F., Kamate, B., ... & Dicko, A. (2021). Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. Malaria Journal, 20(1), 128. https://doi.org/10.1186/s12936-021-03660-2
Gilmartin, C., Nonvignon, J., Cairns, M., Milligan, P., Bocoum, F., Winskill, P., ... & Conteh, L. (2021). Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis. The Lancet Global Health, 9(2), e199-e208. https://doi.org/10.1016/S2214-109X(20)30475-7
Ministère de la Santé. (2023). Annuaire des Statistiques Sanitaires 2023. Cotonou, Bénin.
Nambatya, W., Ocan, M., Robberstad, B., Achan, J., & Idro, R. (2025). Malaria "chemoprevention and vaccination strategies" for children living in endemic areas of Africa: a review. Frontiers in Malaria, 3. https://doi.org/10.3389/fmala.2025.1336324
PSI Nigeria. (2020). DALY Calculation for Malaria PPT (ACT) & Rapid Diagnostic Kit. Récupéré de https://media.psi.org/wp-content/uploads/2020/05/31003029/DALY-for-PPT-final.pdf
Traore, A., Donovan, L., Sawadogo, B., Ward, C., Smith, H., Rassi, C., ... & Gansané, A. (2022). Extending seasonal malaria chemoprevention to five cycles: a pilot study of feasibility and acceptability in Mangodara district, Burkina Faso. BMC Public Health, 22(1), 442. https://doi.org/10.1186/s12889-022-12834-z
Trautmann, S. T., Xu, Y., König-Kersting, C., Patenaude, B. N., Harling, G., Sié, A., & Bärnighausen, T. (2021). Value of statistical life year in extreme poverty: a randomized experiment of measurement methods in rural Burkina Faso. Population Health Metrics, 19(1), 45. https://doi.org/10.1186/s12963-021-00276-z
World Health Organization. (2022). Updated WHO recommendations for malaria chemoprevention among children and pregnant women. Récupéré de https://www.who.int/news/item/03-06-2022-Updated-WHO-recommendations-for-malaria-chemoprevention-among-children-and-pregnant-women
World Health Organization. (2023). World malaria report 2023. Geneva: World Health Organization. Récupéré de https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rilwane DJIBRIL, Chales Patrick MAKOUTODE, SALAMI Lamidhi, MAKIN Mauricette

This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0/
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license term